Krag P, Macnamara F N, Lyng J, Bentzon M W, Larsen S O
Bull World Health Organ. 1965;33(2):243-55.
A yellow fever immune serum was established in 1962 by the WHO Expert Committee on Biological Standardization as the International Reference Preparation of Anti-Yellow-Fever Serum, intended to serve as an immune reference serum in the mouse protection test used in the control of yellow fever vaccines.Before its establishment as the International Reference Preparation, the proposed material was assayed in eleven laboratories in ten countries against a number of other immune and non-immune sera, and was found stable. Neutralization test results were consistent and the relative potency was sufficiently high. This paper not only reports on the collaborative assay, but also discusses errors in the testing method and problems connected with the distribution of mouse deaths during the observation period and with the preparation of dilutions.
1962年,世界卫生组织生物标准化专家委员会将一种黄热病免疫血清确立为抗黄热病血清国际参考制剂,旨在用作黄热病疫苗控制中所用小鼠保护试验的免疫参考血清。在确立为国际参考制剂之前,该候选材料在十个国家的十一个实验室中与许多其他免疫和非免疫血清进行了测定,结果发现其性质稳定。中和试验结果一致,相对效价足够高。本文不仅报告了协作测定情况,还讨论了检测方法中的误差以及与观察期内小鼠死亡分布和稀释液制备相关的问题。